• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

Adamant Global Biotech

+ Add to Watchlist

ADGLBIA:SW

3,059.98 CHF 42.79 1.42%

As of 12:00:00 ET on 01/23/2015.

Snapshot for Adamant Global Biotech (ADGLBIA)

Year To Date: -7.88% 3-Month: +5.51% 3-Year: +37.90% 52-Week Range: 2,071.19 - 3,497.36
1-Month: -8.59% 1-Year: +21.13% 5-Year: - Beta vs SMI: 1.17

Mutual Fund Chart for ADGLBIA

No chart data available.
  • ADGLBIA:SW 3,059.98
  • 1M
  • 1Y
Interactive ADGLBIA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for ADGLBIA

Adamant Global Biotech is an open-end fund incorporated in Switzerland. The objective of the Fund is to obtain long-term capital growth with active management. The Fund invests on a global basis in the shares of companies in the biotech sector.

Inception Date: 10-15-2010 Telephone: +41 800 850 050
Managers: JOHN MANIERI
Web Site: www.zkb.ch/fonds

Fundamentals for ADGLBIA

NAV (on 2015-01-23) 3,059.98
Assets (M) (on 2015-01-23) 147.87
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment -

Dividends for ADGLBIA

Dividend Type Omitted
Dividend Frequency Irreg
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for ADGLBIA

Front Load 2.50
Back Load 1.00
Current Mgmt Fee 1.81
Redemption Fee 1.00
12b1 Fee -
Expense Ratio 1.84

Top Fund Holdings for ADGLBIA

Filing Date: 08/29/2014
Name Position Value % of Total
Gilead Sciences Inc 134,000 13,202,637 9.567%
Amgen Inc 100,000 12,765,117 9.250%
Celgene Corp 145,000 12,618,490 9.144%
Biogen Idec Inc 34,000 10,681,888 7.741%
Alexion Pharmaceuticals Inc 55,000 8,527,434 6.179%
Illumina Inc 43,000 7,063,475 5.119%
Vertex Pharmaceuticals Inc 73,000 6,255,814 4.533%
Salix Pharmaceuticals Ltd 40,000 5,828,836 4.224%
Regeneron Pharmaceuticals Inc 18,000 5,778,427 4.187%
Isis Pharmaceuticals Inc 140,000 5,226,206 3.787%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil